PMGC Holdings Signs LOI for U.S. Electronics Acquisition

ELEVAI Labs Inc. ( (ELAB) ) has provided an update.

On June 9, 2025, PMGC Holdings Inc. announced the signing of a non-binding Letter of Intent to acquire a U.S.-based electronics contract manufacturing company with over 40 years of operational history. This acquisition aligns with PMGC’s strategy of acquiring fundamentally strong U.S. businesses with durable cash flow and growth potential. The target company specializes in high-precision electrical and mechanical assembly, including printed circuit board manufacturing, and generated approximately $699,000 in revenue in 2024. This move positions PMGC at the forefront of the growing U.S. electronics manufacturing services sector, which is benefiting from federal initiatives aimed at revitalizing domestic manufacturing.

Spark’s Take on ELAB Stock

According to Spark, TipRanks’ AI Analyst, ELAB is a Underperform.

ELEVAI Labs Inc. is rated poorly due to major financial weaknesses, including negative revenue and cash flow issues, which are exacerbated by adverse technical indicators. The lack of favorable valuation metrics further weighs down the stock’s score. The absence of applicable corporate events means no positive catalysts are present to offset these challenges.

To see Spark’s full report on ELAB stock, click here.

More about ELEVAI Labs Inc.

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. It currently owns three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC.

Average Trading Volume: 615,384

Technical Sentiment Signal: Sell

Current Market Cap: $2.98M

For a thorough assessment of ELAB stock, go to TipRanks’ Stock Analysis page.